يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Bhorade, S."', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Shah, R. J.; Diamond, J. M.; Cantu, E.; Flesch, J.; Lee, J. C.; Lederer, D. J.; Lama, V. N.; Orens, J.; Weinacker, A.; Wilkes, D. S.; Roe, D.; Bhorade, S.; Wille, K. M.; Ware, L. B.; Palmer, S. M.; Crespo, M.; Demissie, E.; Sonnet, J.; Shah, A.; Kawut, S. M.; Bellamy, S. L.; Localio, A. R.; Christie, J. D. (2015). "Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation." American Journal of Transplantation 15(8): 2188-2196.; https://hdl.handle.net/2027.42/112244Test; American Journal of Transplantation; Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232 – 1241.; Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454 – 1459.; Calfee CS, Matthay MA, Eisner MD, et al. Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med 2011; 183: 1660 – 1665.; Shigemura N, Toyoda Y, Bhama JK, et al. Donor smoking history and age in lung transplantation: A revisit. Transplantation 2013; 95: 513 – 518.; Bonser RS, Taylor R, Collett D, et al. Effect of donor smoking on survival after lung transplantation: A cohort study of a prospective registry. Lancet 2012; 380: 747 – 755.; Vickers AJ, Elkin EB. Decision curve analysis: A novel method for evaluating prediction models. Med Decis Making 2006; 26: 565 – 574.; Moons KG, Donders RA, Stijnen T, Harrell FE, Jr. Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol 2006; 59: 1092 – 1101.; van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007. 16: 219 – 242.; Obesity: Preventing and managing the global epidemic. Report of a WHO consultation World Health Organization technical report series 2000; 894: 1 – 253.; Shah RJ, Diamond JM, Cantu E, et al. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest 2013; 144: 616 – 622.; Christie JD, Bellamy S, Ware LB, et al. Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2010; 29: 1231 – 1239.; Christie JD, Bavaria JE, Palevsky HI, et al. Primary graft failure following lung transplantation. Chest 1998; 114: 51 – 60.; Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart‐lung transplant report‐2012. J Heart Lung Transplant 2012; 31: 1073 – 1086.; Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187: 527 – 534.; Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006; 175: 507 – 513.; Christie JD, Kotloff RM, Ahya VN, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312 – 1316.; Covarrubias M, Ware LB, Kawut SM, et al. Plasma intercellular adhesion molecule‐1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573 – 2578.; Christie JD, Shah CV, Kawut SM, et al. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 2009; 180: 1010 – 1015.; Christie JD, Robinson N, Ware LB, et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 1899; 175: 69 – 74.; Diamond JM, Kawut SM, Lederer DJ, et al. Elevated plasma clara cell secretory protein concentration is associated with high‐grade primary graft dysfunction. Am J Transplant 2011; 11: 561 – 567.; Lederer DJ, Kawut SM, Wickersham N, et al. Obesity and primary graft dysfunction after lung transplantation: The Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med 2011; 184: 1055 – 1061.; Pires‐Neto RC, Morales MMB, Lancas T, et al. Expression of acute‐phase cytokines, surfactant proteins, and epithelial apoptosis in small airways of human acute respiratory distress syndrome. J Crit Care 2013; 28.; Fang A, Studer S, Kawut SM, et al. Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. Chest 2011; 139: 782 – 787.; Hosmer DW, Lemeshow S. Applied logistic regression. 3rd ed. Malden, MA: Wiley‐Interscience; 2000.; Graubard BI, Korn EL. Predictive margins with survey data. Biometrics 1999; 55: 652 – 659.; Lederer DJ, Wilt JS, D'Ovidio F, et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med 2009; 180: 887 – 895.; Greenland S. The need for reorientation toward cost‐effective prediction: Comments on “Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond” by M. J. Pencina et al, Statistics in Medicine (DOI:10.1002/sim.2929). Stat Med 2008; 27: 199 – 206.; Efron B, Tibshirani R. Improvements on Cross‐validation: The 632+ bootstrap method. J Am Stat Assoc 1997; 92: 548 – 560.; Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 1: 527 – 534.; White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011; 30: 377 – 399.